So excited to see this publication finally come out. This was my first project I worked on with the Karnes Lab and I really think it became a diamond from the rough.
Accuracy of warfarin dose prediction algorithms may be improved by including data from diverse populations in genetic studies of dose variability. Here, we surveyed single nucleotide polymorphisms in vitamin K-related genetic pathways for association …
Heparin, a widely used anticoagulant, carries the risk of an antibody-mediated adverse drug reaction, heparin-induced thrombocytopenia (HIT). A subset of heparin-treated patients produces detectable levels of antibodies against complexes of heparin …
Heparin-induced thrombocytopenia (HIT) is an unpredictable, potentially catastrophic adverse effect resulting from an immune response to platelet factor 4 (PF4)/heparin complexes. We performed a genome-wide association study (GWAS) with positive …
I’ve been MIA! Grad school is exhausting! Alas, it’s summer 2021 and I’m back to update my site with some w’s!
American Society of Clinical Pharmacology and Therapeutics Annual Meeting I presented my work on warfarin stable dose prediction in a diverse population featuring a large proportion of Hispanic/Latino reporting warfarin users at the ASCPT 2021 Annual Meeting (,virtually).
Pharmacogenomics Global Research Network (Actually this name is brand new, like yesterday. So in October, when this meeting occurred, the PGRN was still the PharmacoGenomics Research Network).
I presented a poster at the PGRN Annual Meeting in October 2020.